Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

More On TSRX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Trius Therapeutics, Inc. (TSRX)

-NasdaqGM
13.63 0.00(0.00%) Sep 11, 4:00PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.5
Mean Recommendation (last week):2.5
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:14.33
Median Target:14.82
High Target:15.50
Low Target:12.00
No. of Brokers:7

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jul 31, 2013Robert W. BairdDowngradeOutperformNeutral
Nov 19, 2012Aegis CapitalInitiated Buy
Aug 29, 2012WBB SecuritiesInitiated Buy
Dec 23, 2011Robert W. BairdInitiated Outperform
May 26, 2011Global HunterInitiated Buy
Mar 29, 2011Ladenburg ThalmannInitiated Buy
Sep 14, 2010JMP SecuritiesInitiated Mkt Outperform
Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0000
Buy0000
Hold0000
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.